Zydus Lifesciences: Enters Agreement With Lupin To Co-Market Semaglutide Injection In India, Zydus Will Promote It As Semaglyntm, Mashematm, And Altermetm, While Lupin Will Sell It As Semanext And Livarise.
17 Mar 2026 12:01 PM
Zydus Lifesciences: Enters Agreement With Lupin To Co-Market Semaglutide Injection In India, Zydus Will Promote It As Semaglyntm, Mashematm, And Altermetm, While Lupin Will Sell It As Semanext And Livarise.
